0.60
-0.5094(-45.89%)
Currency In USD
| Previous Close | 1.11 |
| Open | 0.64 |
| Day High | 0.71 |
| Day Low | 0.6 |
| 52-Week High | 24 |
| 52-Week Low | 0.6 |
| Volume | 34.83M |
| Average Volume | 3.87M |
| Market Cap | 317,154 |
| PE | -0.02 |
| EPS | -26.4 |
| Moving Average 50 Days | 3.95 |
| Moving Average 200 Days | 7.71 |
| Change | -0.51 |
If you invested $1000 in Helius Medical Technologies, Inc. (HSDT) 10 years ago, it would be worth $0 as of June 13, 2025 at a share price of $0.601. Whereas If you bought $1000 worth of Helius Medical Technologies, Inc. (HSDT) shares 5 years ago, it would be worth $0.05 as of June 13, 2025 at a share price of $0.601.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
GlobeNewswire Inc.
Yesterday at 11:00 AM GMT
-PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of full PoNSTEP study results expanded upon top line
Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device
GlobeNewswire Inc.
Jun 11, 2025 11:00 AM GMT
-Aetna authorizes claim for PoNS Device at out-of-network negotiated price of $18,350, becoming the third payer to join Anthem and United in providing PoNS reimbursement- -Out of Network reimbursement is only the first step towards expanding third-pa
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
GlobeNewswire Inc.
Jun 05, 2025 1:12 AM GMT
NEWTOWN, Pa., June 04, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, toda